Overview This page contains the latest trade data of Penicillins or streptomycins and derivatives, in bulk. In 2022, Penicillins or streptomycins and derivatives, in bulk were the world's 3132nd most traded product, with a total trade of $405M. Between 2021 and 2022 the exports of Penicillins or streptomycins and derivatives, in bulk decreased by -11.7%, from $459M to $405M. Trade in Penicillins or streptomycins and derivatives, in bulk represent 0.0017% of total world trade.
Penicillins or streptomycins and derivatives, in bulk are a part of Unpackaged Medicaments.
Exports In 2022 the top exporters of Penicillins or streptomycins and derivatives, in bulk were United Kingdom ($103M), China ($74.5M), Spain ($35.8M), Belgium ($32.8M), and Saudi Arabia ($31.3M).
Imports In 2022 the top importers of Penicillins or streptomycins and derivatives, in bulk were Algeria ($42.9M), Austria ($41.8M), Italy ($36.8M), Egypt ($29M), and Belgium ($28M).
Ranking Penicillins or streptomycins and derivatives, in bulk ranks 1997th in the Product Complexity Index (PCI).
Description Penicillins are used to treat bacterial infections, such as food poisoning and pneumonia. Penicillins may also be used to treat mycobacterial or fungal infections, but they are not as effective as other drugs. Streptomycins are used to treat tuberculosis, tularemia, and other serious bacterial infections.